International › Germany · Last reviewed 2026-05-16
Germany
Summary
German care for adolescents with gender dysphoria is based on an AWMF S2k clinical guideline (registry no. 028-014). The Dutch Health Council noted in 2026 that, unlike in England and Sweden, treatment in Germany has recently been anchored more firmly in revised guidelines and expert statements (source). The Selbstbestimmungsgesetz, in force since 1 November 2024, regulates legal gender recognition and does not relate to medical treatment (source).
1. AWMF S2k guideline
The Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) registers an S2k guideline on gender incongruence and gender dysphoria in childhood and adolescence (registry no. 028-014). In its 2026 advice the Dutch Health Council counts Germany among the countries where treatment with GnRH agonists and gender-affirming hormones has recently been anchored more firmly in revised guidelines and expert statements (source).21
2. Selbstbestimmungsgesetz (2024)
The German Selbstbestimmungsgesetz (in force as of 1 November 2024) lets people change their registered gender entry and first names by a declaration at the registry office, without a court decision or expert reports (source). The law does not concern medical treatment: gender-affirming medical measures are not regulated in it.
See also
- HTA reports on the evidence base: Cass Review, SBU
- Original protocol description: Delemarre 2006
- International guidelines overview: Guidelines international
- Worldwide overview: Status 2025
- International comparison — Germany alongside other countries in table.
- Timeline — policy decisions chronologically.
- FAQ · Glossary.
Footnotes
- AWMF S2k-Leitlinie "Geschlechtsinkongruenz und Geschlechtsdysphorie im Kindes- und Jugendalter", registry no. 028-014.
- Gezondheidsraad. Transgenderzorg voor jongeren, advice no. 2026/12, 30 June 2026.